Rosetta Genomics Ltd. 3,000,000 Ordinary Shares* Underwriting AgreementUnderwriting Agreement • September 21st, 2006 • Rosetta Genomics Ltd. • Pharmaceutical preparations • New York
LICENSE AGREEMENTLicense Agreement • September 21st, 2006 • Rosetta Genomics Ltd. • Pharmaceutical preparations
At the Max-Planck-Institute for Biophysical Chemistry in Goettingen, an institute of the Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V. (hereinafter “MPG“), a German non-profit scientific research organisation, Dr. Thomas Tuschl and other scientists of MPG have discovered certain microRNA sequences (internal GI file No. GI 2916 ZJE). MPG has filed certain MPG Patent Rights (as later defined herein) relating thereto.
EXCLUSIVE LICENSE AGREEMENT BETWEEN THE JOHNS HOPKINS UNIVERSITY ROSETTA GENOMICS LTD JHU Ref: # - 4950Exclusive License Agreement • September 21st, 2006 • Rosetta Genomics Ltd. • Pharmaceutical preparations • Maryland
THIS LICENSE AGREEMENT (the “Agreement”) is entered into by and between THE JOHNS HOPKINS UNIVERSITY, a Maryland corporation having an address at 3400 N. Charles Street, Baltimore, Maryland, 21218-2695 (“JHU”) and Rosetta Genomics Ltd., an Israeli corporation having an address at 10 Plaut St. Rehovot (“Company”), with respect to the following:
LICENSE AGREEMENT (the “Agreement”)License Agreement • September 21st, 2006 • Rosetta Genomics Ltd. • Pharmaceutical preparations • New York
Ambion, Inc., a Delaware corporation having its principal office at 2130 Woodward St., Austin, Texas 78744, hereinafter “AMBION”. AMBION and ROSETTA may be referred to individually as the “Party” or collectively as the “Parties”.
RESEARCH AND LICENSE AGREEMENT (HVC)Research and License Agreement • September 21st, 2006 • Rosetta Genomics Ltd. • Pharmaceutical preparations
This agreement (the "Agreement") is made and entered into as of the 30 day of May, 2005 (the "Effective Date") by and between Rosetta Genomics Ltd., a private company registered under the laws of the State of Israel, of 10 Plaut Street, Science Park, Rehovot, Israel ("Rosetta") and Hadasit Medical Research Services and Development Ltd., a private company registered under the laws of the state of Israel, of Hadassah Medical Hospital, POB 12000, Jerusalem, Israel ("Hadasit").
The Rockefeller University License AgreementLicense Agreement • September 21st, 2006 • Rosetta Genomics Ltd. • Pharmaceutical preparations • New York
This Agreement (this “Agreement”) is between The Rockefeller University, a New York nonprofit corporation (“Rockefeller”), and Rosetta Genomics Ltd., an Israeli corporation (“Company”). This Agreement will become effective on May 4, 2006 (the “Effective Date”).
